gvtcx

supplier

Techdow Pharma England Ltd

GU27YG combined from 3 published records

as a supplier

11 recorded awards from 5 buyers , between 17 Jan 2019 and 28 Nov 2025.

awards won
11
exclusive
0%
0 sole-winner awards
median award
£240.8m
largest
£295.0m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

buyerawards
NHS England 5
NHS England 2
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") 2
Regional Business Services Organisation Procurement and Logistics Service 1
The NHS Commissioning Board (operating under the name of NHS England) 1

contracts won

contractbuyervalueawarded
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products shared NHS England £321,349,256 28 Nov 2025
CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins shared NHS England £186,609,000 13 Jul 2023
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared NHS England £251,930,337 4 Jul 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 shared Regional Business Services Organisation, Procurement and Logistics Service · 3 Jul 2026
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products shared NHS England · 18 Dec 2025
NP35925 Cardiovascular & Respiratory Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 6 May 2025
NP35923 Cardiovascular & Respiratory Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · 25 Jul 2023
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared The NHS Commissioning Board (operating under the name of NHS England) · 23 Feb 2021

every contract won by Techdow Pharma England Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Techdow Pharma England Ltd · GU2 7YG 6
TECHDOW PHARMA ENGLAND LIMITED GB-COH 10513412 GU2 7YG 3
Techdow Pharma England Ltd GB-PPON PTVB-7163-QNVJ GU2 7YG 2

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works